Lucas Vitzthum
Overview
Explore the profile of Lucas Vitzthum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
92
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Butler S, No H, Guo F, Merchant G, Park N, Jackson S, et al.
JACC CardioOncol
. 2025 Jan;
6(6):935-945.
PMID: 39801654
Background: Atrial fibrillation (AF) has been associated with thoracic radiotherapy, but the specific risk with irradiating different cardiac substructures remains unknown. Objectives: This study sought to examine the relationship between...
2.
Qu V, Hui C, Fang Z, Jackson S, Vitzthum L, Rahimy E, et al.
J Gastrointest Oncol
. 2024 Sep;
15(4):1487-1496.
PMID: 39279929
Background: Hope is correlated with quality of life and overall survivorship among patients with cancer. We aimed to identify sociodemographic and clinical determinants of hope among patients with gastrointestinal (GI)...
3.
Shi M, Simiele E, Han B, Pham D, Palomares P, Aguirre M, et al.
Adv Radiat Oncol
. 2024 Jan;
9(1):101300.
PMID: 38260216
Purpose: The aim of this study was to present the first-year experience of treating patients using intensity modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) with a biology-guided...
4.
Liu L, Shen L, Johansson A, Balter J, Cao Y, Vitzthum L, et al.
Med Phys
. 2023 Nov;
51(4):2526-2537.
PMID: 38014764
Background: Volumetric reconstruction of magnetic resonance imaging (MRI) from sparse samples is desirable for 3D motion tracking and promises to improve magnetic resonance (MR)-guided radiation treatment precision. Data-driven sparse MRI...
5.
Eke I, Guo H, Loo Jr B, Sung A, Diehn M, Vitzthum L, et al.
Pract Radiat Oncol
. 2023 May;
13(5):e383-e388.
PMID: 37150318
We present the case of a woman with metastatic adenoid cystic carcinoma who received stereotactic ablative radiation therapy with a total dose of 50 Gy in 4 fractions to 2...
6.
Alhusaini S, Lanman T, Ko R, Therkelsen K, von Eyben R, Diehn M, et al.
Front Oncol
. 2023 Apr;
13:1139940.
PMID: 37035171
Objective: The 2-year incidence of brain metastases (BrMs) in stage III non-small lung cell cancer (NSCLC) has been estimated to be around 30%. However, recent clinical trials have demonstrated considerably...
7.
Simiele E, Han B, Skinner L, Pham D, Lewis J, Gensheimer M, et al.
Adv Radiat Oncol
. 2023 Apr;
8(5):101186.
PMID: 37035034
Purpose: The aim of this study was to apply the Six Sigma methodology and failure mode and effect analysis (FMEA) to mitigate errors in intensity modulated radiation therapy (IMRT) and...
8.
Taieb D, Wanna G, Ahmad M, Lussey-Lepoutre C, Perrier N, Nolting S, et al.
Lancet Diabetes Endocrinol
. 2023 Apr;
11(5):345-361.
PMID: 37011647
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might...
9.
Hui C, Baclay R, Lau B, von Eyben R, Vitzthum L, Pollom E, et al.
Pract Radiat Oncol
. 2023 Mar;
13(2):e139-e148.
PMID: 36868725
Purpose: Although arterial phase enhancement is commonly used to evaluate treatment response for hepatocellular carcinoma, it may not accurately describe response for lesions treated with stereotactic body radiation therapy (SBRT)....
10.
Nief C, No H, Louie C, Vitzthum L, Das M
Clin Lung Cancer
. 2022 Nov;
24(1):76-81.
PMID: 36323592
No abstract available.